LI Ying, LIU Qiang, CHEN Xiao-qing. Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
Citation:
|
LI Ying, LIU Qiang, CHEN Xiao-qing. Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
|
LI Ying, LIU Qiang, CHEN Xiao-qing. Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
Citation:
|
LI Ying, LIU Qiang, CHEN Xiao-qing. Effect of Pembrolizumab in Advanced Triple-Negative Breast Cancer Patients[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 147-149. DOI: 10.12019/j.issn.1671-5144.2018.03.006
|